Drospirenone for peak identification
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 67392-87-4
Synonym(S): Drospirenone, 6β,7β:15β,16β -Dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbolactone, Dihydrospirorenone
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 MG | Y0001718-10-MG | In Stock | ₹ 14,267.35 |
Y0001718 - 10 MG
In Stock
Quantity
1
Base Price: ₹ 14,267.35
GST (18%): ₹ 2,568.123
Total Price: ₹ 16,835.473
grade
pharmaceutical primary standard
API family
drospirenone
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7
InChI
1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1
InChI key
METQSPRSQINEEU-HXCATZOESA-N
Gene Information
human ... NR3C2(4306) , PGR(5241)
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Selleck Chemical LLC Drospirenone 100mg 67392-87-4 ZK 3059 | -- | ₹ 30,493.58 | |
| | Selleck Chemical LLC Drospirenone 25mg 67392-87-4 ZK 3059 | -- | ₹ 13,039.34 | |
| | Sigma Aldrich Fine Chemicals Biosciences Drospirenone >=98% (HPLC) | 67392-87-4 | MFCD00867350 | 50MG | -- | ₹ 40,981.53 | |
| | Sigma Aldrich Fine Chemicals Biosciences Drospirenone European Pharmacopoeia (EP) Reference Standard | 67392-87-4 | MFCD00867350 | | -- | ₹ 16,350.52 | |
| | Sigma Aldrich Fine Chemicals Biosciences Drospirenone United States Pharmacopeia (USP) Reference Standard | 67392-87-4 | MFCD00867350 | 200MG | -- | ₹ 45,791.71 | |
| | Drospirenone | -- | ₹ 22,299.50 | |
| | Drospirenone | -- | ₹ 40,756.13 | |
| | Drospirenone | -- | ₹ 14,267.35 | |
| | 67392-87-4 | Drospirenone | -- | ₹ 4,192.44 - ₹ 70,501.44 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Drospirenone for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
- Biochem/physiol Actions: Drospirenone is a fourth-generation progestin that has antimineralocorticoid, and antiandrogenic activity in addition to potent progestogenic activity. In two recent studies drospirenone appeared to double the risk of venous thromboembolism compared to levonorgestrel, although other studies found little added risk.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Repr. 1B
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable